Tahiben injection solution 5 ampl / 10ml 5mg/ml Urapidil Тахибен

Tahiben (urapidil)

Tahiben contains the active ingredient urapidil, alpha-1 adrenoceptor antagonist (antihypertensive).

Tahiben Indications

Hypertensive crisis, severe hypertension, refractory hypertension, controlled (controlled) reduction of blood pressure when it is increasing at and / or after surgery.

Dosage & Administration 

Intravenous injections: 10-50 mg urapidylu injected slowly with constant monitoring of blood pressure (BP). Lowering blood pressure can be expected within 5 minutes after injection. Depending on the clinical effect can be repeated intravenous drug (at a dose of 10-50 mg urapidylu).

Intravenous drip infusion or infusion using perfuzatora: to maintain blood pressure levels achieved by injection, the drug is administered by infusion.

Preparation of the solution for infusion:

– Intravenous drip infusion of 250 mg urapidylu (50 ml) was added to 500 mL of 0.9% sodium chloride solution for infusion or 5% or 10% glucose solution for infusion.
– Intravenous infusion using perfuzatora 100 mg urapidylu (20 ml) are gaining in perfuzator and diluted to a volume of 50 mL of 0.9% sodium chloride solution for infusion or 5% or 10% glucose solution for infusion.

Contradictions

Hypersensitivity to urapidilu or other ingredients, aortic stenosis, arteriovenous shunt (with the exception of hemodynamically inactive shunt for dialysis).

Browse more blood pressure available with international delivery.